http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009033941-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b186ba02c290819bad17b17bed0c66b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f95b713c313118e71569dab28c14ad3f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efd09c296645384c4e1c770411f7aa01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f5897d09f6c4e4165853e7be9b4282d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bddf0cd3a995058247d69ac3fab7e04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b4f255e460a669c68e0f0e97ed4dd23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_499eba0342de0b9bfc90b585740f1cb7 |
| publicationDate | 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2009033941-A1 |
| titleOfInvention | A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent |
| abstract | The present invention relates to a method for predicting a response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent, said method comprising the steps of : a) obtaining a biological sample from said patient; b) determining the pattern of expression level of at least one gene of the group comprising AKR1C1, MLPH, ESR1, PGR, COMP, DCN, IGKC, CCL5, FBNl and/or UBE2C, or of genes coregulated therewith, in said sample; c) comparing the pattern of expression levels determined in (b) with one or several reference pattern (s) of expression levels; d) identifying at least one marker gene; e) determining a molecular subtype for said sample on the basis of (d); and f) predicting from said molecular subtype response of a tumor for a chemotherapeutic agent, wherein the molecular subtype is selected from the group comprising the subtypes basal, stromal-high, stromal-low, luminal A, immune system-high, immune system-low, proliferation-high and/or proliferation-low. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101890387-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013532489-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017055769-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180063004-A |
| priorityDate | 2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 709.